Pharmaceutical

Genmab’s Tivdak approved in Japan for advanced cervical cancer

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

Mar 29, 2025 - 06:00
Genmab’s Tivdak approved in Japan for advanced cervical cancer
Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.
Read the original article

Tags:

Previous Article

Weill Cancer Hub East launches to transform treatment

Next Article

Soleno wins FDA approval for Prader-Willi hyperphagia treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Launching pharmaceuticals in Belgium, the Netherlands, and Luxembourg: Opportunities and challenges

Launching pharmaceuticals in Belgium, the Netherlands, ...

Sep 21, 2023

RareStone’s narcolepsy therapy receives approval in China

RareStone’s narcolepsy therapy receives approval in China

Jul 5, 2023

Opinion: The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs

Opinion: The FDA and FTC need to crack down on TikTok a...

Jan 22, 2024